Immunohistochemistry analysis suggests a lower expression of the proliferation markers Ki67, AR, AR-v7, and PSA in SBI-46-treated mice than in vehicle-treated mice (Figure 5C,F).These experiments indicate that the oral administration of SBI-46 exerts an inhibitory effect on the tumor mass. This evidence concerns the gene MKI67 and neoplasm.